OsteoarthritisNCT00764959
Retrospective Study of the Linear™ Hip
An observational study of Osteoarthritis and Rheumatoid Arthritis, run by Encore Medical, L.P. at 1 site in United States.
Trial summary
The purpose of this study is to evaluate the use and efficacy of the Encore Linear™ Hip System in a group of 200 patients for whom data has already been collected. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Osteoarthritis, Rheumatoid Arthritis, Femoral Fracture
- What is being tested?
- Encore Linear™ Hip System
- Type of treatment
- Medical device
- How many people
- 200 participants
- Where
- 1 siteUnited States
- Study dates
- Oct 2007to Feb 2011
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Individuals who meet the indications for use of the Linear Hip device AND who meet the inclusion/exclusion criteria
Who may be able to join
- Have hip joint disease related to one or more of the following
- osteoarthritis
- rheumatoid arthritis
- femoral fracture
- correction of a functional deformity
- avascular necrosis of the natural femoral head
Show all 13Show fewer
- Skeletal maturity
- Patient is likely to be available for evaluation for the duration of the study
- Able and willing to sign the informed consent and follow study procedures
- Patient is not pregnant
- No infection present
- No known materials sensitivity
- Patient is over 18 years of age
Who cannot join
- Skeletal immaturity
- Infection or sepsis
- Insufficient bone quality that may affect the stability of the implant
- Muscular, neurologic or vascular deficiencies which compromise the affected extremity
- Alcoholism or other addictions
- Prisoners
Show all 11Show fewer
- High levels of physical activity
- Patient is pregnant
- Loss of ligamentous structures
- Materials sensitivity
- Patient is under 18 years of age
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Post-Market Study of the Linear™ Hip System
The purpose of this study is to evaluate the use and efficacy of the Encore Linear™ Hip System in a group of 200 patients for whom data has already been collected.
- Conditions
- Osteoarthritis, Rheumatoid Arthritis, Femoral Fracture, Correction of a Functional Deformity, Avascular Necrosis
- Being tested
- Encore Linear™ Hip System
- Medical subject headings
- Osteoarthritis, Arthritis, Rheumatoid, Femoral Fractures, Osteonecrosis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Encore Linear™ Hip SystemDevice
Subjects with degenerative joint disease (DJD), osteoarthritis or rheumatoid arthritis, have received the hip system and are willing to participate in the study.
| Study group | Role | What they receive |
|---|---|---|
| Linear Hip | Encore Linear Hip System Receives: Device: Encore Linear™ Hip System |
What is being measured
The primary outcome is the main question the study is designed to answer.
The use and efficacy of the Encore Linear™ Hip System
Measured: 2 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Oct 2008 (estimated)
- Study startOct 2007
- Primary completionFeb 2011
- Study completionFeb 2011
Why it stopped: Enrollment and data collection insufficient to continue study.
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for OsteoarthritisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 200 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Encore Medical, L.P.
- Sponsor type
- Industry (pharma, biotech, devices)
- Investigators
- Omar Hussamy, M.D., Principal investigator, Hussamy Orthopedics
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00764959
- Sponsor's protocol ID
- PS - 800
- Status last verified
- Feb 2011
- First submitted
- 30 Sep 2008
- Last updated
- 9 Feb 2011
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 9 Feb 2011. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Post-Market Study of the Linear™ Hip System
- ClinicalTrials.gov ID
- NCT00764959
- Acronym / sponsor ID
- PS - 800
- Conditions
- Osteoarthritis, Rheumatoid Arthritis, Femoral Fracture, Correction of a Functional Deformity, Avascular Necrosis
- Study type
- Observational
- Recruitment status
- TerminatedReason stopped: Enrollment and data collection insufficient to continue study.
- Enrolment
- 200 participants (estimated)
- Lead sponsor
- Encore Medical, L.P.Industry (pharma, biotech, devices)
- Study start
- Oct 2007
- Primary completion
- Feb 2011 (actual)
- Study completion
- Feb 2011 (actual)
- First posted
- 2 Oct 2008 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to evaluate the use and efficacy of the Encore Linear™ Hip System in a group of 200 patients for whom data has already been collected.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Linear Hip | – | Device: Encore Linear™ Hip SystemEncore Linear Hip System |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Individuals who meet the indications for use of the Linear Hip device AND who meet the inclusion/exclusion criteria
Key inclusion criteria (13 listed)
- Have hip joint disease related to one or more of the following
- Skeletal maturity
- Patient is likely to be available for evaluation for the duration of the study
- Able and willing to sign the informed consent and follow study procedures
- Patient is not pregnant
Key exclusion criteria (11 listed)
- Skeletal immaturity
- Infection or sepsis
- Insufficient bone quality that may affect the stability of the implant
- Muscular, neurologic or vascular deficiencies which compromise the affected extremity
- Alcoholism or other addictions
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Encore Linear™ Hip SystemSubjects with degenerative joint disease (DJD), osteoarthritis or rheumatoid arthritis, have received the hip system and are willing to participate in the study. | Device | Linear Hip |
Primary outcome
The use and efficacy of the Encore Linear™ Hip System
Time frame: 2 year
Results and safety
The study was stopped early (reason given: Enrollment and data collection insufficient to continue study.). Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Feb 2011.
- Sponsor Company home pageLink provided by the sponsor.
Related trials for Osteoarthritis
Not yet recruiting
Holistic Healing for Knee Osteoarthritis
Knee Osteoarthritis (Knee OA)
Active, not recruiting
Effectiveness of Therapeutic Exercises on Spinopelvic Mobility
Osteoarthritis (OA) of the Hip
Recruiting
Effect of Anti-inflammatory Diet in Osteoarthritis
Osteoarthritis, Knee
Active, not recruitingPhase 2/3
Single vs Triple Hyaluronic Acid in Knee Osteoarthritis
Osteoarthritis, Knee
Not yet recruiting
The Feasibility of a Virtual/Home-based OA Treatment Program in Older Adults With OA and Multimorbidity
Osteoarthritis of the Knee
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Omar Hussamy, M.D. principal investigator
Hussamy Orthopedics
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Osteoarthritis and Rheumatoid Arthritis, run by Encore Medical, L.P. at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 13 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: stopped early, as of the sponsor's last update on 9 Feb 2011. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was stopped early (reason given: Enrollment and data collection insufficient to continue study.). Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The use and efficacy of the Encore Linear™ Hip System (time frame: 2 year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Feb 2011.